A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
08/2002
08/15/2002	CA2437717A1 G-protein coupled receptors
08/15/2002	CA2437573A1 Methods for diagnosing and treating heart disease
08/15/2002	CA2437570A1 Methods for diagnosing and treating heart disease
08/15/2002	CA2437503A1 Hepatitis b virus treatment
08/15/2002	CA2437423A1 Nucleic acid expressed in the hypothalamus or muscle tissue in obese animals
08/15/2002	CA2437267A1 Mixture of peptides originating from a nef protein and applications thereof
08/15/2002	CA2436470A1 Intracellular signaling molecules
08/15/2002	CA2436334A1 Adhesion molecules
08/15/2002	CA2433439A1 Proteins and nucleic acids encoding same
08/14/2002	EP1231277A2 Biocompatible implant for in vivo formation of a neo-organ
08/14/2002	EP1231274A2 Modified porteinase inhibitors
08/14/2002	EP1231269A1 Methods and compositions for polypeptide engineering
08/14/2002	EP1230934A1 Polyion complex micelles of core/shell structure
08/14/2002	EP1230394A1 Lentiviral vector transduction of hematopoietic stem cells
08/14/2002	EP1230389A1 Antisense inhibition of pi3 kinase p55 gamma expression
08/14/2002	EP1230378A2 An oncolytic adenovirus
08/14/2002	EP1230375A1 Inhibiting gene expression with dsrna
08/14/2002	EP1230369A2 Polypeptide hormone phosphatonin
08/14/2002	EP1230367A1 19 human secreted proteins
08/14/2002	EP1230364A2 Compositions and methods for the therapy and diagnosis of prostate cancer
08/14/2002	EP1230360A2 15 human secreted proteins
08/14/2002	EP1230357A2 Genes differentially expressed in tr1 cells and their use in the manufacture of immunoregulatory compositions
08/14/2002	EP1230356A2 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds
08/14/2002	EP1230349A2 Nucleic acids encoding endotheliases, endotheliases and uses thereof
08/14/2002	EP1230342A1 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues
08/14/2002	EP1230341A1 Geranyl diphosphate synthase large subunit, and methods of use
08/14/2002	EP1230338A1 Continuous-flow method for preparing microparticles
08/14/2002	EP1230268A2 Heteroclitic analogs of class i epitopes
08/14/2002	EP1230267A2 Membrane translocating peptide drug delivery system
08/14/2002	EP1230264A1 Therapeutic compositions and methods for treating disease states with mutant forms of myeloid progenitor inhibitory factor-2 (mpif-2)
08/14/2002	EP1230255A1 25 human secreted proteins
08/14/2002	EP1230254A1 Antisense modulation of src-3 expression
08/14/2002	EP1230214A2 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof
08/14/2002	EP1229941A2 Nucleic acid-containing complex
08/14/2002	EP1229933A2 Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof
08/14/2002	EP1229932A2 Induction of mucosal immunity by vaccination via the skin route
08/14/2002	EP1229931A1 Fusion proteins of mycobacterium tuberculosis
08/14/2002	EP1229795A2 Human chemokine beta-13
08/14/2002	EP0937098B1 Recombinational cloning in vitro using engineered recombination sites
08/14/2002	EP0831879B1 Method for identifying or isolating a molecule and molecules identified thereby
08/14/2002	EP0806964B1 Chemical compounds
08/14/2002	EP0800399B1 Combined therapeutical treatment of hyperproliferative diseases
08/14/2002	EP0697876B1 Xenograft thymus
08/14/2002	DE10158523A1 Hemmung der Transkription eines Zielgens in einer Zelle oder in Geweben Inhibition of transcription of a target gene in a cell or in tissue
08/14/2002	CN1364197A Vector for expressing two foreign genes
08/14/2002	CN1364172A Transcriptional activation inhibitory protein
08/14/2002	CN1364171A Polypeptide dendrimers as unimolecular carriers of diagnostic imaging contrast agents, bioactive substances and drugs
08/14/2002	CN1364087A Methods of treatment and drug screening methods
08/13/2002	US6433451 Method and electric motor with rotational stator
08/13/2002	US6433155 Isolated cdna or rna polynucleotide comprising nucleic acid sequence encoding polypeptide comprising specified amino acid sequence, or fragment thereof
08/13/2002	US6433154 Functional receptor/kinase chimera in yeast cells
08/13/2002	US6433143 Tie-2 ligands
08/13/2002	US6433139 Secreted protein HPEAD48
08/13/2002	US6433138 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids
08/13/2002	US6432927 Compositions and methods for inducing gene expression
08/13/2002	US6432926 Compositions and methods for treating papillomavirus-infected cells
08/13/2002	US6432925 RNA cancer vaccine and methods for its use
08/13/2002	US6432917 Anticancer agents
08/13/2002	US6432916 Compounds and methods for treatment and diagnosis of chlamydial infection
08/13/2002	US6432914 Cancer diagnosis; polypeptide
08/13/2002	US6432709 Encapsidation cell lines and expression vectors for transcomplementation of defective retroviral vectors
08/13/2002	US6432707 Isolation of polynucleootide
08/13/2002	US6432700 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same
08/13/2002	US6432699 Sindbis viral vectors for transducing target cells for gene encoding a chimeric envelope protein
08/13/2002	US6432676 Insulin production and transformation of cells
08/13/2002	US6432655 Binding and 5-ht receptors and gene expression
08/13/2002	US6432644 Diagnosing polymorphism in humans
08/13/2002	US6432406 Method for reducing angiogenesis by administration of a scatter factor inhibitor
08/08/2002	WO2002061113A2 Nucleic acid derived vaccine that encodes an antigen linked to a polypeptide that promotes antigen presentation
08/08/2002	WO2002061110A2 Nucleic acid derivatives
08/08/2002	WO2002061104A2 Hybrid adenoviral vector
08/08/2002	WO2002061086A2 Human leucine-rich repeat containing protein expressed predominately in small intestine, hlrrsi1
08/08/2002	WO2002061081A1 A novel gene bn01 mapping to chromosome 16q24.3
08/08/2002	WO2002061076A1 Adiponectin-associated protein
08/08/2002	WO2002061075A1 Novel g protein-coupled receptor protein and dna thereof
08/08/2002	WO2002061074A1 Novel protein and dna thereof
08/08/2002	WO2002061069A1 Runx3 gene showing anti-tumor activity and use thereof
08/08/2002	WO2002061053A1 Renal stem cells and uses thereof
08/08/2002	WO2002061046A2 Novel nucleic acid and polypeptide molecules
08/08/2002	WO2002061040A2 Gene delivery formulations and methods for treatment of ischemic conditions
08/08/2002	WO2002061037A2 Administration of nucleic acid sequence to female animal
08/08/2002	WO2002061033A2 Transfection of human embryonic stem cells
08/08/2002	WO2002060951A2 Methods and compositions for reducing heparan sulfate proteoglycan-mediated clearance of factor viii
08/08/2002	WO2002060950A2 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
08/08/2002	WO2002060944A1 Peptides specific to tcr cdr3 of infiltrating t cells derived from patients with psoriasis and uses thereof
08/08/2002	WO2002060937A1 Universal carrier for targeting molecules to gb3 receptor expressing cells
08/08/2002	WO2002060930A2 Method for the identification of extracellular domains of the epstein barr virus (ebv), tumor-associated latent membrane proteins and for the selection of antibody reagents reactive therewith
08/08/2002	WO2002060928A2 Medane genes and proteins
08/08/2002	WO2002060490A1 Retroviral vector
08/08/2002	WO2002060479A1 Use of il-18 inhibitors for the treatment and/or prevention of heart disease
08/08/2002	WO2002060467A2 Compositions and methods for improving kidney function
08/08/2002	WO2002060412A2 Stabilised polymeric aerosols for pulmonary gene delivery
08/08/2002	WO2002034903A3 Nucleic acid generating the abca7 gene, molecules modulating its activity and therapeutic applications
08/08/2002	WO2002034901A8 Protein kinase
08/08/2002	WO2002030455A3 Agents for the treatment of viral infections
08/08/2002	WO2002029062A3 Cytokine proteins
08/08/2002	WO2002028165A3 Compositions and methods of using capsid protein from flaviviruses and pestiviruses
08/08/2002	WO2002026192A3 Viruses targeted to hypoxic cells and tissues
08/08/2002	WO2002022175A3 Method and composition for treating tumors by selective induction of apoptosis
08/08/2002	WO2002022161A3 The diagnosis, prevention, and/or treatment of atherosclerosis and underlying and/or related diseases

1 ... 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 ... 870